Ga-DOTA PET/CT: the first-line functional imaging modality in the management of patients with neuroendocrine tumors

Mesquita, Cláudio Tinoco; Palazzo, Isabella Caterina; Rezende, Maria Fernanda.
Radiol. bras ; 55(2): 3-4, mar.-abr. 2022.
Artículo en Inglés | LILACS-Express | ID: biblio-1365301

Documentos relacionados

  1. [The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
  2. [Occult mediastinal node involvement in non-small cell lung cancer after negative uptake on PET/CT: ripples through staging and therapy. Case report and critical review].
  3. [PET/CT: Molecular Imaging and Theranostics for Radionuclide Therapy].
  4. Head-to-head comparison between <sup>18</sup> F-DOPA PET/CT and <sup>68</sup> Ga-DOTA peptides PET/CT in detecting intestinal neuroendocrine tumours: A systematic review and meta-analysis.
  5. [(18)F-FDG PET/CT: Image-guided surveillance in advanced head and neck cancer as an alternative to neck dissection].
  6. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.
  7. PET/CT: Clinical role in lymphomas.
  8. [Tumor staging with PET/CT. Detection of a second tumor].
  9. Paediatric metastatic ganglioneuroblastoma on 68Ga-DOTA NOC PET-CT.
  10. PET/CT: Nasopharyngeal Cancers.